„”
What keeps us healthy and what makes us sick? How does a drug reach the right target in the body? Conversely, how can viruses and bacteria be prevented from entering cells and tissues? We work on these questions by investigating biochemical processes in cells and organs and by studying the molecular causes of diseases. We also conduct targeted drug research or develop novel diagnostics and therapeutics that form the basis of tomorrow's medicine.
More
FMP provides an excellent working environment, training and support to equip you with the skills needed for a scientific career and a healthy work-life balance. We foster tolerant and creative collaboration and adhere to the rules of good scientific practice.
The keeping of laboratory animals and the performance of experiments on animals are subject to strict regulations based on the EU-Directive 2010/63/EU, which has been implemented at the national level by the Prevention of Cruelty to Animals Act (Tierschutzgesetz - TierSchG) as of July 23, 2013 and the Directive for the Protection of Laboratory Animals (Tierschutz-Versuchstierverordnung - TierSchVersV) as of August 01, 2013.
Laboratory animal report of FMP for the year 2025
Read more about the Animal Facility
"Tierversuche verstehen"-Initiative
"Transparente Tierversuche" Initiative
The Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) is part of the Forschungsverbund Berlin e.V. (FVB), which legally represents seven non-university research institutes - members of the Leibniz Association - in Berlin.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Rudower Chaussee 17
12489 Berlin, Germany
